BORTENAT-BORTEZOMIB INJECTION

Get a Price/Quote

MOQ : 1 Bottle

BORTENAT-BORTEZOMIB INJECTION Specification

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Salt Composition
Bortezomib (as Bortezomib for Injection) 2 mg/vial

Dosage Form
Injection

Enzyme Types
Other

Feature
Sterile, Preservative Free

Ingredients
Bortezomib

Application
Anticancer Therapy

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 Months

Packaging Type
Single-use vial

Brand Name
Bortenat

Therapeutic Class
Antineoplastic Agent

Status
For hospital/clinic use only

Prescription/Non prescription
Prescription only

Strength
2 mg

Administration
Intravenous or Subcutaneous injection

BORTENAT-BORTEZOMIB INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Supply Ability
100 Bottles Per Day

Delivery Time
7 Hours

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About BORTENAT-BORTEZOMIB INJECTION

BORTENAT

Available as: 2 mg & 3.5 mg Vial

Manufactured By: NATCO

Specifications

Brand:Bortenat
Packaging Type:Pack Of 1 Vial
Strength:2MG & 3.5 MG
Packaging Size:Pack Of 1 Vial

NOTE: Bortenat is A prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug................

Precision Treatment for Cancer

BORTENAT (Bortezomib Injection) offers targeted antineoplastic therapy, effectively addressing conditions such as multiple myeloma and mantle cell lymphoma. Its precise delivery and formulation maximize its therapeutic impact, enhancing patient outcomes under professional supervision.

Safe Hospital-Grade Administration

Each BORTENAT injection comes in a single-use sterile vial, ensuring safety and minimizing contamination. Administered either intravenously or subcutaneously, the process is strictly managed by healthcare professionals within hospitals or clinical environments, adhering to best medical practices.

Proper Storage and Handling

To maintain efficacy, BORTENAT requires storage below 25C and protection from light. As a preservative-free, hospital-grade medication, strict handling protocols guarantee the integrity and effectiveness of each dose throughout its 24-month shelf life.

FAQs of BORTENAT-BORTEZOMIB INJECTION:

Q: How is BORTENAT-BORTEZOMIB Injection administered?

A: BORTENAT Injection is administered by a healthcare professional via intravenous or subcutaneous injection. This ensures precise dosing and minimizes the risk of complications during cancer treatment.

Q: What conditions is BORTENAT-BORTEZOMIB prescribed for?

A: BORTENAT is specifically indicated for the treatment of multiple myeloma and mantle cell lymphoma, as supported by its antineoplastic properties and therapeutic effectiveness.

Q: When should BORTENAT-BORTEZOMIB Injection be used?

A: BORTENAT Injection should only be used under the guidance and prescription of an oncologist or qualified healthcare provider, almost exclusively in a hospital or clinical setting.

Q: Where should BORTENAT-BORTEZOMIB be stored?

A: Store the injection below 25C, protected from direct light, and always check that the vial remains intact until use to preserve its sterility and efficacy.

Q: What are the steps involved in the administration process?

A: A nurse or doctor will prepare the single-use vial, administer the correct dosage intravenously or subcutaneously, and monitor the patient throughout and after the injection for safety.

Q: What are the benefits of using BORTENAT over other anticancer agents?

A: BORTENAT offers a targeted approach to cancer therapy, delivering effective results in controlling multiple myeloma and mantle cell lymphoma, with sterile, preservative-free dosing that minimizes the risk of adverse reactions.

Tell us about your requirement